Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial

BACKGROUND: The rapid worldwide spread of COVID-19 has caused a global health challenge with high mortality of severe or critically ill patients with COVID-19. To date, there is no specific efficient therapeutics for severe or critically ill patients with COVID-19. It has been reported that androgen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Dawei, Ju, Minjie, Wang, Hao, Jia, Yichen, Wang, Xiaodan, Fang, Hao, Fan, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268455/
https://www.ncbi.nlm.nih.gov/pubmed/37322522
http://dx.doi.org/10.1186/s40360-023-00678-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268455/
https://www.ncbi.nlm.nih.gov/pubmed/37322522
http://dx.doi.org/10.1186/s40360-023-00678-7

Ejemplares similares